InvestorsHub Logo
Followers 18
Posts 6649
Boards Moderated 0
Alias Born 03/06/2010

Re: Pharma Sleuth post# 383616

Tuesday, 08/01/2023 3:15:19 PM

Tuesday, August 01, 2023 3:15:19 PM

Post# of 401578
I see your point, but don’t forget the following:
- We are on the OTC.
- No investment funds can buy this stock.
- There is a long history of failure no ROI for shareholders with this company.
- As investors place trust in management, the share price is compensated believing that the strategic plans will be executed. Trust is harder to rebuild than doing what you say you will and don’t, time and time again. It’s much, much harder to rebuild credibility. This is Elite’s situation.
- How much will CEO milk Elite for Mikah? Until Mikah and Elite fully separate, this relationship will be a Bain for shareholders. The CEO is blind to this fact.
- CFO leaving is a bigger red flag than when a CEO leaves. When 3 CFOs leave in quick succession, you’re in uncharted waters weighing down on the stock. Knowing the past, shareholders are waiting for another shoe to drop because it often does.
- Retail shareholders don’t have the financial firepower to lift this company out of the cellar.
- Management ignores retail shareholders because they provide no value to the company. Sad, but it’s the reality. No IR likes dealing with the retail side and are more often than not, ignored. If you own 10%, now you might have a seat at the table.

These are just a handful of factors of why the stock price is where it is. Simply don’t ignore the risks.

On the flip side, when will we hit the point where the future potential outweighs those risks. That’s the discussion to be had.